CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | -5.3% | 115 | 0.0% | 0.00% | – |
| Q2 2023 | $169 | -11.1% | 115 | 0.0% | 0.00% | – |
| Q1 2023 | $190 | +18.0% | 115 | 0.0% | 0.00% | – |
| Q4 2022 | $161 | – | 115 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 115 | -86.2% | 0.00% | -100.0% |
| Q2 2022 | $2,000 | 0.0% | 831 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -60.0% | 831 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $5,000 | -16.7% | 831 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $6,000 | +500.0% | 831 | +748.0% | 0.00% | +300.0% |
| Q2 2021 | $1,000 | 0.0% | 98 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |